Physician
High Point Pediatrics
High Point Pediatrics was paid $10.62M by Medicaid between Jan 2018 and Dec 2024, across 70 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 19% of everything it billed.
33Billing provider infoHIGH POINT PEDIATRICS
HIGH POINT, NC 27262
HIGH POINT, NC 27262
33aNPI1922198977assigned 10/13/2006
33bProvider typePediatrics Physician
28Total paid$10.62M
24GClaims464,345
24DCodes billed70
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in North Carolina
Rank by total paid#31 of 433
Median peer was paid$942K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,757 | $875K | |
| 2019 | 34,610 | $1.12M | |
| 2020 | 24,112 | $818K | |
| 2021 | 68,191 | $1.83M | |
| 2022 | 110,508 | $2.44M | |
| 2023 | 101,131 | $1.94M | |
| 2024incomplete | 94,036 | $1.60M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 21,467 | 18,756 | $1.98M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 28,720 | 25,166 | $1.75M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 13% | 10,319 | 8,857 | $1.35M |
| 99199 | Unlisted special service, procedure or report | 12% | 233,223 | 152,629 | $1.29M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 7.8% | 3,617 | 2,833 | $827K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.4% | 6,173 | 5,544 | $571K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.8% | 5,078 | 4,459 | $508K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.1% | 16,521 | 14,987 | $331K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.9% | 9,240 | 8,455 | $311K |
| 99401 | 2.3% | 6,934 | 5,470 | $245K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.2% | 8,397 | 7,121 | $235K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.2% | 2,551 | 2,373 | $235K |
58 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 1,569 | $136K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,696 | $105K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,551 | $94K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,792 | $92K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,673 | $84K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,981 | $67K |
| 99051 | <1% | 2,312 | $57K | |
| 90837 | Psychotherapy session, about an hour | <1% | 571 | $52K |
| 92552 | <1% | 15,810 | $37K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,609 | $36K |
| 96127 | <1% | 6,876 | $34K | |
| 85018 | <1% | 19,416 | $32K | |
| 90651 | <1% | 1,103 | $32K | |
| 81002 | <1% | 11,739 | $25K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 181 | $22K |
| 69210 | <1% | 528 | $16K | |
| 90734 | <1% | 510 | $8K | |
| G0315 | Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt) | <1% | 285 | $8K |
| 81025 | <1% | 890 | $6K | |
| 90686 | <1% | 3,979 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 333 | $6K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 116 | $4K |
| G0312 | Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes) | <1% | 123 | $4K |
| 90633 | <1% | 1,313 | $3K | |
| 90620 | <1% | 39 | $3K | |
| 90474 | <1% | 135 | $3K | |
| 0072A | <1% | 43 | $3K | |
| 0071A | <1% | 33 | $2K | |
| D1206 | Topical application of fluoride varnish | <1% | 116 | $2K |
| 0001A | <1% | 20 | $1K | |
| 99173 | <1% | 9,734 | $1K | |
| 99177 | <1% | 4,512 | $875.09 | |
| 87807 | <1% | 41 | $579.33 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 200 | $508.50 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 45 | $478.46 |
| 90688 | <1% | 130 | $437.60 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 29 | $414.91 |
| 36410 | <1% | 26 | $345.69 | |
| 90656 | <1% | 186 | $259.82 | |
| 90619 | <1% | 150 | $152.41 | |
| 90716 | <1% | 91 | $124.91 | |
| 90715 | <1% | 43 | $43.25 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 27 | $1.06 |
| 90671 | <1% | 53 | $0.08 | |
| 90677 | <1% | 14 | $0.06 | |
| 90670 | <1% | 1,079 | $0.01 | |
| 91300 | 0% | 41 | $0.00 | |
| 90700 | 0% | 12 | $0.00 | |
| 90707 | 0% | 92 | $0.00 | |
| 90698 | 0% | 320 | $0.00 | |
| 91307 | 0% | 156 | $0.00 | |
| 99174 | 0% | 263 | $0.00 | |
| 90680 | 0% | 186 | $0.00 | |
| 99000 | 0% | 242 | $0.00 | |
| 91305 | 0% | 27 | $0.00 | |
| 94760 | 0% | 15 | $0.00 | |
| 90744 | 0% | 37 | $0.00 | |
| 90696 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMYERS, MARYBETH (DOCTOR)